Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biotools
  • Published:

Protein Sequencing as a Tool in Clinical Trials

Bio/Technology volume 12, pages 627–628 (1994)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schlesinger, D.H., ed. 1988. Macromolecular sequencing and synthesis: Selected methods and applications. New York: R. Liss, Inc.

    Google Scholar 

  2. Deutscher, M.P., ed. 1990. Methods in enzymology: Guide to Protein purification, vol. 182, New York: Academic Press.

    Google Scholar 

  3. Kent, S., Hood, L., Aebersold, R., Teplow, D., Smith, L., Farnsworth, V., Cartier, P., Hines, W., Hughes, P., and Dodd, C. 1987. Approaches to sub-picomole protein sequencing. BioTechniques 5: 314.

    CAS  Google Scholar 

  4. Hunkapiller, M.W., Granlund-Moyer, K., and Whiteley, N.W. 1986. Gas-phase proteinlpeptide sequencer in methods of protein microcharacterization. J.E. Shively, ed. Clifton, New Jersey: Humana Press.

    Google Scholar 

  5. U.S. Food and Drug Administration, Center for Drugs and Biologics. Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology. April 10, 1985.

  6. U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. Supplement to the points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology: Nucleic acid characterization and genetic stability. April 6, 1992.

  7. Doleman, M.S., Emery, C., and Forde, D. 1993. Protein sequencing techniques to demonstrate stability in formulated protein drugs. Poster presented at the seventh symposium of the Protein Society, San Diego, California.

  8. Farnsworth, V., Carson, W., and Krutzsch, H. 1991. Reduced chemical background noise in automated protein sequencers. Peptide Res. 4: 245.

    CAS  Google Scholar 

  9. Haniu, M., and Shively, J.E. 1988. Microsequence analysis of peptides and proteins. IX. Manual gas-phase microsequencing of multiple samples. Anal. Biochem. 173: 296.

    Article  CAS  Google Scholar 

  10. Tetzlaff, R.F. 1992. GMP Documentation requirements for automated systems. Pharm. Technol. Intern. September: 30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. research scientist in the protein analysis group at Applied Biosystems/Perkin-Elmer in Foster City, CA

    Jin Dong Zhao

  2. the principal of M.J. Pramik, Larkspur, CA

    Mary Jean Pramik

Authors
  1. Jin Dong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Jean Pramik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, J., Pramik, M. Protein Sequencing as a Tool in Clinical Trials. Nat Biotechnol 12, 627–628 (1994). https://doi.org/10.1038/nbt0694-627

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0694-627

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing